| Literature DB >> 24196071 |
A A Roger Thompson1, Philip M Elks, Helen M Marriott, Suttida Eamsamarng, Kathryn R Higgins, Amy Lewis, Lynne Williams, Selina Parmar, Gary Shaw, Emmet E McGrath, Federico Formenti, Fredericus J Van Eeden, Vuokko L Kinnula, Christopher W Pugh, Ian Sabroe, David H Dockrell, Edwin R Chilvers, Peter A Robbins, Melanie J Percy, M Celeste Simon, Randall S Johnson, Stephen A Renshaw, Moira K B Whyte, Sarah R Walmsley.
Abstract
Neutrophil lifespan and function are regulated by hypoxia via components of the hypoxia inducible factor (HIF)/von Hippel Lindau/hydroxylase pathway, including specific roles for HIF-1α and prolyl hydroxylase-3. HIF-2α has both distinct and overlapping biological roles with HIF-1α and has not previously been studied in the context of neutrophil biology. We investigated the role of HIF-2α in regulating key neutrophil functions. Human and murine peripheral blood neutrophils expressed HIF-2α, with expression up-regulated by acute and chronic inflammatory stimuli and in disease-associated inflammatory neutrophil. HIF2A gain-of-function mutations resulted in a reduction in neutrophil apoptosis both ex vivo, through the study of patient cells, and in vivo in a zebrafish tail injury model. In contrast, HIF-2α-deficient murine inflammatory neutrophils displayed increased sensitivity to nitrosative stress induced apoptosis ex vivo and increased neutrophil apoptosis in vivo, resulting in a reduction in neutrophilic inflammation and reduced tissue injury. Expression of HIF-2α was temporally dissociated from HIF-1α in vivo and predominated in the resolution phase of inflammation. These data support a critical and selective role for HIF-2α in persistence of neutrophilic inflammation and provide a platform to dissect the therapeutic utility of targeting HIF-2α in chronic inflammatory diseases.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24196071 PMCID: PMC3894493 DOI: 10.1182/blood-2013-05-500207
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113